Concepedia

Kalaiselvi Natarajan

KN

6

Publications

159

Citations

6

H-Index

2015

Active since

Affiliations

Leipzig University(Current)

Kalaiselvi Natarajan is an author at Leipzig University specializing in medicine, molecular signaling, and tumor biology.

ORCID

Top concepts

Publications per year

2015–2019

6

Publications

6

Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a

Nagarajan Elumalai, Angela Berg, Kalaiselvi Natarajan et al. · Angewandte Chemie International Edition · 2015 · 63 citations · Full text

Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b

Nagarajan Elumalai, Angela Berg, Stefan Rubner et al. · Scientific Reports · 2017 · 43 citations · Full text

Stafia‐1: a STAT5a‐Selective Inhibitor Developed via Docking‐Based Screening of in Silico O‐Phosphorylated Fragments

Kalaiselvi Natarajan, Daniel Müller‐Klieser, Stefan Rubner et al. · Chemistry - A European Journal · 2019 · 20 citations · Full text

Halogen-substituted catechol bisphosphates are potent and selective inhibitors of the transcription factor STAT5b

Nagarajan Elumalai, Kalaiselvi Natarajan, Thorsten Berg · Bioorganic & Medicinal Chemistry · 2017 · 12 citations · Full text

Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a

Nagarajan Elumalai, Angela Berg, Kalaiselvi Natarajan et al. · Angewandte Chemie · 2015 · 11 citations · Full text

, , +18

Rows per page

1–5 of 6